2024年10月2日 · Ozempic is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise • as monotherapy when metformin is …

OZEMPIC is a glucagon-like peptide 1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (1). Not …

When Ozempic is added to existing therapy of sulfonylurea or insulin, a reduction in the dose of sulfonylurea or insulin should be considered to reduce the risk of hypoglycaemia (see sections …

*Additional information is available within the SPC or upon request to the company

Ozempic is a diabetes medicine used with diet and exercise to treat adults whose type 2 diabetes is not satisfactorily controlled. Ozempic can be used on its own in patients who cannot take …

Ozempic je určený na liečbu dospelých s nedostatočne kompenzovaným diabetom mellitus 2. typu ako doplnok diéty a cvičenia ako monoterapia, keď sa metformín považuje za nevhodný z …

Přípravek Ozempic je indikován k léčbě dospělých s nedostatečně kontrolovaným diabetem mellitem 2. typu jako doplněk k dietním opatřením a cvičení • jako monoterapie, pokud je …

Official information about Ozempic from the EMA website: SPC for healthcare professionals and package leaflet for the public.

2024年10月1日 · Ozempic® is used to treat adults (aged 18 years and older) with type 2 diabetes when diet and exercise is not enough: on its own – when you cannot use metformin (another …

OZEMPIC is indicated: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus[see Clinical Studies (14.1)]. to reduce the risk of major adverse...